The Scientist

» pharmaceuticals and neuroscience

Most Recent

image: Spinal Cord Injury Researcher Dies

Spinal Cord Injury Researcher Dies

By | February 23, 2017

Neuroscientist Geoffrey Raisman pioneered the study of spinal cord injury and the use of cell transplants to repair the damage.

0 Comments

image: ADHD Linked to Structural Differences in the Brain

ADHD Linked to Structural Differences in the Brain

By | February 21, 2017

Imaging data show smaller volumes in several brain regions among people diagnosed with the behavioral disorder.

0 Comments

image: Infant Brain Scans May Predict Autism Diagnosis

Infant Brain Scans May Predict Autism Diagnosis

By | February 17, 2017

A computer algorithm can identify the brains of autism patients with moderate accuracy based on scans taken at six months and one year of age.

0 Comments

image: Consilience, Episode 1: Smarty Plants

Consilience, Episode 1: Smarty Plants

By | February 13, 2017

A conversation with plant biologists on the age-old dispute over the similarities and differences between plants and animals.

2 Comments

With its purchase of Actelion, Johnson & Johnson’s acquires experimental treatments for pulmonary arterial hypertension and several rare diseases.

0 Comments

A team of scientists was unable to replicate controversial, high-profile findings published in 2011.

0 Comments

image: As the Brain Ages, Glial-Cell Gene Expression Changes Most

As the Brain Ages, Glial-Cell Gene Expression Changes Most

By | January 10, 2017

Researchers describe how gene expression in different human brain regions is altered with age.

1 Comment

image: Neural Mechanism Links Alcohol Consumption to Binge Eating

Neural Mechanism Links Alcohol Consumption to Binge Eating

By | January 10, 2017

Ethanol triggers starvation-activated neurons, leading mice to overeat. 

0 Comments

image: Takeda to Buy Cancer Drug Maker Ariad for $5.2 Billion

Takeda to Buy Cancer Drug Maker Ariad for $5.2 Billion

By | January 10, 2017

The pharma giant’s purchase of the US firm includes the acquisition of investigative cancer drugs.

0 Comments

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS